Artykuły w czasopismach na temat „Transcriptional co-activator with PDZ-Binding motif (TAZ)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Transcriptional co-activator with PDZ-Binding motif (TAZ)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Wu, Chia-Lin, Chia-Chu Chang, Tao-Hsiang Yang, et al. "Tubular transcriptional co-activator with PDZ-binding motif protects against ischemic acute kidney injury." Clinical Science 134, no. 13 (2020): 1593–612. http://dx.doi.org/10.1042/cs20200223.
Pełny tekst źródłaHuang, Yao, Xueqian Ouyang, Jinghua Tan, Zhenyu Meng, Xiuwen Ma, and Yiguo Yan. "The physiological and pathogenic roles of yes-associated protein/transcriptional co-activator with PDZ-binding motif in bone or skeletal motor system-related cells." Cytojournal 22 (February 8, 2025): 13. https://doi.org/10.25259/cytojournal_237_2024.
Pełny tekst źródłaLiu, Tao, Jiaojiao Zhou, Yanmin Chen, et al. "Genome-Wide Characterization of TAZ Binding Sites in Mammary Epithelial Cells." Cancers 15, no. 19 (2023): 4713. http://dx.doi.org/10.3390/cancers15194713.
Pełny tekst źródłaSalem and Hansen. "The Hippo Pathway in Prostate Cancer." Cells 8, no. 4 (2019): 370. http://dx.doi.org/10.3390/cells8040370.
Pełny tekst źródłaTiffon, Camille, Julie Giraud, Silvia Elena Molina-Castro, et al. "TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties." Cells 9, no. 6 (2020): 1462. http://dx.doi.org/10.3390/cells9061462.
Pełny tekst źródłaMAHONEY, William M., Jeong-Ho HONG, Michael B. YAFFE, and Iain K. G. FARRANCE. "The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members." Biochemical Journal 388, no. 1 (2005): 217–25. http://dx.doi.org/10.1042/bj20041434.
Pełny tekst źródłaChu, Cong-Qiu, and Taihao Quan. "Fibroblast Yap/Taz Signaling in Extracellular Matrix Homeostasis and Tissue Fibrosis." Journal of Clinical Medicine 13, no. 12 (2024): 3358. http://dx.doi.org/10.3390/jcm13123358.
Pełny tekst źródłaWarren, Janine, Yuxuan Xiao, and John Lamar. "YAP/TAZ Activation as a Target for Treating Metastatic Cancer." Cancers 10, no. 4 (2018): 115. http://dx.doi.org/10.3390/cancers10040115.
Pełny tekst źródłaPark, Sangryong, Ho-Young Lee, Jayoung Kim, et al. "Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells." Cancers 13, no. 5 (2021): 1125. http://dx.doi.org/10.3390/cancers13051125.
Pełny tekst źródłaLauriola, Angela, Elisa Uliassi, Matteo Santucci, et al. "Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library." Pharmaceutics 14, no. 2 (2022): 391. http://dx.doi.org/10.3390/pharmaceutics14020391.
Pełny tekst źródłaLiu, Yuchen, Xiaohui Wang, and Yingzi Yang. "Hepatic Hippo signaling inhibits development of hepatocellular carcinoma." Clinical and Molecular Hepatology 26, no. 4 (2020): 742–50. http://dx.doi.org/10.3350/cmh.2020.0178.
Pełny tekst źródłaChen, Guangyuan, Ping Huang, Jiabin Xie, and Rihong Li. "Overexpression of transcriptional co-activator with PDZ-binding motif promotes epithelial mesenchymal transformation of ovarian cancer cells by upregulating Smad3 and Snail1." Materials Express 10, no. 1 (2020): 120–26. http://dx.doi.org/10.1166/mex.2020.1617.
Pełny tekst źródłaVan Haele, Matthias, Iván Moya, Ruçhan Karaman, et al. "YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role." International Journal of Molecular Sciences 20, no. 3 (2019): 638. http://dx.doi.org/10.3390/ijms20030638.
Pełny tekst źródłaEl Yousfi, Younes, Rocío Mora-Molina, Abelardo López-Rivas, and Rosario Yerbes. "Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells." Cells 12, no. 19 (2023): 2370. http://dx.doi.org/10.3390/cells12192370.
Pełny tekst źródłaThrash, Hannah L., and Ann Marie Pendergast. "Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis." Cancers 15, no. 19 (2023): 4701. http://dx.doi.org/10.3390/cancers15194701.
Pełny tekst źródłaZhang, Jinglin, Yuhang Zhou, Patrick Tang, et al. "Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis." International Journal of Molecular Sciences 20, no. 7 (2019): 1576. http://dx.doi.org/10.3390/ijms20071576.
Pełny tekst źródłaTóth, Marcell, Shan Wan, Jennifer Schmitt, et al. "The Cell Polarity Protein MPP5/PALS1 Controls the Subcellular Localization of the Oncogenes YAP and TAZ in Liver Cancer." International Journal of Molecular Sciences 26, no. 2 (2025): 660. https://doi.org/10.3390/ijms26020660.
Pełny tekst źródłaGandhirajan, Rajesh Kumar, Manaswita Jain, Benedikt Walla, et al. "CysteineS-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ)." Journal of Biological Chemistry 291, no. 22 (2016): 11596–607. http://dx.doi.org/10.1074/jbc.m115.712539.
Pełny tekst źródłaDi Benedetto, Giorgia, Silvia Parisi, Tommaso Russo, and Fabiana Passaro. "YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming." Metabolites 11, no. 3 (2021): 154. http://dx.doi.org/10.3390/metabo11030154.
Pełny tekst źródłaKim, Jongwan, Haiyan Jin, Jinhyuk Kim, et al. "Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket." International Journal of Molecular Sciences 25, no. 10 (2024): 5358. http://dx.doi.org/10.3390/ijms25105358.
Pełny tekst źródłaElisi, Gian, Matteo Santucci, Domenico D’Arca, et al. "Repurposing of Drugs Targeting YAP-TEAD Functions." Cancers 10, no. 9 (2018): 329. http://dx.doi.org/10.3390/cancers10090329.
Pełny tekst źródłaSung, Mi Sun, So Young Kim, Gwang Hyeon Eom, and Sang Woo Park. "High VEGF Concentrations Accelerate Human Trabecular Meshwork Fibrosis in a TAZ-Dependent Manner." International Journal of Molecular Sciences 24, no. 11 (2023): 9625. http://dx.doi.org/10.3390/ijms24119625.
Pełny tekst źródłaQu, Huinan, Da Qi, Xinqi Wang, et al. "CLDN6 Suppresses c–MYC–Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer." International Journal of Molecular Sciences 23, no. 1 (2021): 129. http://dx.doi.org/10.3390/ijms23010129.
Pełny tekst źródłaShrestha, Madhu, Toshinori Ando, Chanbora Chea, et al. "The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation." Carcinogenesis 40, no. 10 (2019): 1288–97. http://dx.doi.org/10.1093/carcin/bgz023.
Pełny tekst źródłaAndo, Toshinori, Kento Okamoto, Tomoaki Shintani, et al. "Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine." Journal of Personalized Medicine 12, no. 10 (2022): 1544. http://dx.doi.org/10.3390/jpm12101544.
Pełny tekst źródłaAhmad, Usama Sharif, Jutamas Uttagomol, and Hong Wan. "The Regulation of the Hippo Pathway by Intercellular Junction Proteins." Life 12, no. 11 (2022): 1792. http://dx.doi.org/10.3390/life12111792.
Pełny tekst źródłaMiyajima, Chiharu, Yurika Hayakawa, Yasumichi Inoue, Mai Nagasaka, and Hidetoshi Hayashi. "HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ." Pharmaceuticals 15, no. 8 (2022): 1015. http://dx.doi.org/10.3390/ph15081015.
Pełny tekst źródłaPlewes, Michele R., Xiaoying Hou, Pan Zhang, et al. "Yes-associated protein 1 is required for proliferation and function of bovine granulosa cells in vitro†." Biology of Reproduction 101, no. 5 (2019): 1001–17. http://dx.doi.org/10.1093/biolre/ioz139.
Pełny tekst źródłaZuo, Q.-F., R. Zhang, B.-S. Li, et al. "MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ." Cell Death & Disease 6, no. 1 (2015): e1623-e1623. http://dx.doi.org/10.1038/cddis.2014.573.
Pełny tekst źródłaStrakova, Zuzana, Jennifer Reed, Mark Livak, and Ivanna Ihnatovych. "Localization of Transcriptional Co-Activator with PDZ Binding Motif (TAZ) in Human Endometrium and Its Involvement in the Regulation of Decidualization." Biology of Reproduction 81, Suppl_1 (2009): 398. http://dx.doi.org/10.1093/biolreprod/81.s1.398.
Pełny tekst źródłaZhao, Wanxia, Ziteng Wang, Yichen Lei, et al. "Investigating InDels in YAP and TAZ genes and their impact on growth characteristics in goats." Archives Animal Breeding 67, no. 3 (2024): 343–51. http://dx.doi.org/10.5194/aab-67-343-2024.
Pełny tekst źródłaCherrett, Claire, Makoto Furutani-Seiki, and Stefan Bagby. "The Hippo pathway: key interaction and catalytic domains in organ growth control, stem cell self-renewal and tissue regeneration." Essays in Biochemistry 53 (August 28, 2012): 111–27. http://dx.doi.org/10.1042/bse0530111.
Pełny tekst źródłaLee, Jieun, Moonhyung Choi, Seungyeon Joe, Kabsoo Shin, Sung-Hak Lee, and Ahwon Lee. "Growth Pattern of Hepatic Metastasis as a Prognostic Index Reflecting Liver Metastasis-Associated Survival in Breast Cancer Liver Metastasis." Journal of Clinical Medicine 11, no. 10 (2022): 2852. http://dx.doi.org/10.3390/jcm11102852.
Pełny tekst źródłaWan, Qiuyuan, Qing Chen, Dongge Cai, Yan Zhao, and Xiaoling Wu. "OTUB2 Promotes Homologous Recombination Repair Through Stimulating Rad51 Expression in Endometrial Cancer." Cell Transplantation 29 (January 1, 2020): 096368972093143. http://dx.doi.org/10.1177/0963689720931433.
Pełny tekst źródłaLiu, Fei, David Lagares, Kyoung Moo Choi, et al. "Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis." American Journal of Physiology-Lung Cellular and Molecular Physiology 308, no. 4 (2015): L344—L357. http://dx.doi.org/10.1152/ajplung.00300.2014.
Pełny tekst źródłaWang, Chenji, Jian An, Pingzhao Zhang, et al. "The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation." Biochemical Journal 444, no. 2 (2012): 279–89. http://dx.doi.org/10.1042/bj20111983.
Pełny tekst źródłaMondal, Varsha, Paul J. Higgins, and Rohan Samarakoon. "Emerging Role of Hippo-YAP (Yes-Associated Protein)/TAZ (Transcriptional Coactivator with PDZ-Binding Motif) Pathway Dysregulation in Renal Cell Carcinoma Progression." Cancers 16, no. 15 (2024): 2758. http://dx.doi.org/10.3390/cancers16152758.
Pełny tekst źródłaWang, Yongshun, Wei Cao, Jinjin Cui, et al. "Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway." Cellular Physiology and Biochemistry 51, no. 2 (2018): 842–53. http://dx.doi.org/10.1159/000495376.
Pełny tekst źródłaLaiman, Vincent, Didik Setyo Heriyanto, Yueh-Lun Lee, et al. "Zinc Oxide Nanoparticles Promote YAP/TAZ Nuclear Localization in Alveolar Epithelial Type II Cells." Atmosphere 13, no. 2 (2022): 334. http://dx.doi.org/10.3390/atmos13020334.
Pełny tekst źródłaKodaka, Manami, Fengju Mao, Kyoko Arimoto-Matsuzaki, et al. "Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells." PLOS ONE 15, no. 4 (2020): e0231265. http://dx.doi.org/10.1371/journal.pone.0231265.
Pełny tekst źródłaUmegaki, Toshihito, Hisashi Moriizumi, Fumiko Ogushi, Mutsuhiro Takekawa, and Takashi Suzuki. "Molecular dynamics simulations of a multicellular model with cell-cell interactions and Hippo signaling pathway." PLOS Computational Biology 20, no. 11 (2024): e1012536. http://dx.doi.org/10.1371/journal.pcbi.1012536.
Pełny tekst źródłaHong, Ganji, Ying Yan, Yali Zhong, Jianer Chen, Fei Tong, and Qilin Ma. "Combined Ischemic Preconditioning and Resveratrol Improved Bloodbrain Barrier Breakdown via Hippo/YAP/TAZ Signaling Pathway." CNS & Neurological Disorders - Drug Targets 18, no. 9 (2020): 713–22. http://dx.doi.org/10.2174/1871527318666191021144126.
Pełny tekst źródłaLee, Hyun Ji, Yong Jun Hong, and Miri Kim. "Angiogenesis in Chronic Inflammatory Skin Disorders." International Journal of Molecular Sciences 22, no. 21 (2021): 12035. http://dx.doi.org/10.3390/ijms222112035.
Pełny tekst źródłaSteinberg, Thorsten, Martin Philipp Dieterle, Imke Ramminger, et al. "On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence." International Journal of Molecular Sciences 24, no. 16 (2023): 12677. http://dx.doi.org/10.3390/ijms241612677.
Pełny tekst źródłaTang, Miaolu, Kaitlyn Dirks, Soo Yeon Kim, Jessica Thorpe, and Wei Li. "Abstract 2910: Targeting thioredoxin reductase 1 (TrxR1) suppresses TAZ-driven glioblastoma progression." Cancer Research 84, no. 6_Supplement (2024): 2910. http://dx.doi.org/10.1158/1538-7445.am2024-2910.
Pełny tekst źródłaMohagheghi, Sina, Zohreh Khajehahmadi та Heidar Tavilani. "Signaling in Simple Steatosis and Non-alcoholic Steatohepatitis Cirrhosis: TGF-β1, YAP/TAZ, and Hedgehog Pathway Activity". Avicenna Journal of Medical Biochemistry 6, № 2 (2018): 26–30. http://dx.doi.org/10.15171/ajmb.2018.07.
Pełny tekst źródłaMasliantsev, Konstantin, Lucie Karayan-Tapon, and Pierre-Olivier Guichet. "Hippo Signaling Pathway in Gliomas." Cells 10, no. 1 (2021): 184. http://dx.doi.org/10.3390/cells10010184.
Pełny tekst źródłaChen, Yen-Lin, I.-Chuan Yen, Kuen-Tze Lin, Feng-Yi Lai та Shih-Yu Lee. "4-Acetylantrocamol LT3, a New Ubiquinone from Antrodia cinnamomea, Inhibits Hepatocellular Carcinoma HepG2 Cell Growth by Targeting YAP/TAZ, mTOR, and WNT/β-Catenin Signaling". American Journal of Chinese Medicine 48, № 05 (2020): 1243–61. http://dx.doi.org/10.1142/s0192415x20500615.
Pełny tekst źródłaAbou Nader, Nour, Amélie Ménard, Adrien Levasseur, et al. "Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate." International Journal of Molecular Sciences 23, no. 21 (2022): 13585. http://dx.doi.org/10.3390/ijms232113585.
Pełny tekst źródłaJi, Xinyan, Lihua Song, Li Sheng, et al. "Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation." Cancers 10, no. 11 (2018): 449. http://dx.doi.org/10.3390/cancers10110449.
Pełny tekst źródła